Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

DGAP-News: Carl Zeiss Meditec acquires two manufacturers of surgical instruments


DGAP-News: Carl Zeiss Meditec AG / Key word(s): Takeover
Carl Zeiss Meditec acquires two manufacturers of surgical instruments

19.04.2022 / 16:00
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec acquires two manufacturers of surgical instruments
 
Carl Zeiss Meditec announced today the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider
 

Jena/Germany | 19 April 2022

Kogent Surgical and Katalyst Surgical are based in Chesterfield, Missouri (USA) and were founded by entrepreneur Gregg Scheller. Carl Zeiss Meditec AG President and CEO Dr. Markus Weber states: "This is a strategically important acquisition for ZEISS Medical Technology. We expect this acquisition to scale the businesses and contribute to our surgical solution offering and add recurring revenue." Gregg Scheller comments: "We already have a successful, long-term partnership with ZEISS and FCI (France Chirurgie Instrumentation S.A.S.) and we look forward to jointly expanding our solutions into other ZEISS applications and customer specialties." Financial terms of the deal are not disclosed.

Contact for investors and the press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: [email protected]


www.zeiss.com/newsroom
 



19.04.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: [email protected]
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1327727

 
End of News DGAP News Service

1327727  19.04.2022 

fncls.ssp?fn=show_t_gif&application_id=1327727&application_name=news&site_id=sharewise

Carl Zeiss Meditec AG Aktie

66,65 €
-2,13 %
Heute geht es für Carl Zeiss Meditec AG merklich abwärts mit einem Rückgang von -2,13 %.
Die Community ist gespalten bezüglich Carl Zeiss Meditec AG, mit 2 Buy- und 1 Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 122 € für Carl Zeiss Meditec AG bedeutet eine mögliche Steigerung um über 50% im Vergleich zu 66.65 €.
Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare